Anebulo Pharmaceuticals, Inc.ANEBNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-6.35M
↓ 10% below average
Average (5y)
$-5.76M
Historical baseline
Range
High:$-150770.00
Low:$-9.68M
CAGR
+111.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-6.35M | +21.5% |
| 2024 | $-8.09M | +16.4% |
| 2023 | $-9.68M | -78.1% |
| 2022 | $-5.44M | -11.6% |
| 2021 | $-4.87M | -3130.9% |
| 2020 | $-150770.00 | - |